Minerva Neurosciences, Inc. (NERV)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

3.18 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2024, ended 31 Dec 2024, as filed

Revenue

$0.00

Net income

$1.44M

Free cash flow

$19.55M

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
2 May 2023	Luthringer Remy CEO	Sold at will	$13.69K	5.0%
1 May 2023	Luthringer Remy CEO	Sold at will	$91.45K	24.6%
1 May 2023	Race Geoff President	Sold at will	$85.02K	30.1%
1 May 2023	Ahlholm Frederick W SVP, CFO and Secretary	Sold at will	$16.04K	17.0%
1 Dec 2021	Kupfer David Director	Sold, plan not stated	$48.96K	25.4%
16 Dec 2020	Race Geoff EVP, CFO & CBO	Sold, plan not stated	$16.34K	2.8%

47out of 100

Profitability 25

Financial strength 17

Growth 100

Insiders 50

Strongest on growth (100), weakest on financial strength (17). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan